MedPath

Role of inflammatory markers in recurrent pregnancy loss and effect of oral micronized therapy on these cases

Not Applicable
Completed
Conditions
Health Condition 1: null- pregnant patients with history of recurrent abortions and pregnant patients without recurrent aBORTIONS
Registration Number
CTRI/2016/09/007278
Lead Sponsor
All India Institute of Medical Sciences new delhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
90
Inclusion Criteria

1)Pregnant females at 21â??40 years of age;

2)Euthyroid state with normal thyroid function tests

3)All women who had two or more than two consecutive miscarriages of unknown cause

Exclusion Criteria

Women with a history of repeated miscarriage of known cause.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
levels of cytokines in peripheral blood in women with RPL, effect of oral micronized progesterone on the cytokines and pentraxin 3 levels, effect of oral micronized progesterone on the pregnancy outcome in women with recurrent pregnancy loss, effect of oral micronized progesterone on the pregnancy outcome in relation to the cytokine levelsTimepoint: recruitment, 16 weeks, post delivery, post abortion
Secondary Outcome Measures
NameTimeMethod
levels of cytokine in peripheral blood in normal pregnancy, perinatal outcome , occurrence of obstetric <br/ ><br>complications like ICP, pre eclampsiaTimepoint: recruitment, 16 weeks, post delivery
© Copyright 2025. All Rights Reserved by MedPath